Most Institutions Measure Discovery. Not Impact.

The Cure Innovation Index benchmarks 303 U.S. research institutions, giving you a clear view of where you stand, where the gaps are, and where to focus next across three dimensions.
Research Capabilities
The depth and quality of an institution’s translational research engine.
Market 
Translation
How effectively discoveries move from lab to clinical and commercial use.
Entrepreneurial Readiness
The ecosystem capacity to support faculty founders and spinout activity.

“It’s difficult for academic institutions to translate discovery into real-world impact. The Cure Innovation Index brings clarity to where that translation is working and where it isn’t.”

Thomas P. Sakmar, MD

Professor, Chemical Biology, Rockefeller University

“The risk isn’t a lack of breakthroughs, it’s that we’re not investing enough in translating them into real-world impact. The Cure Innovation Index shows what it actually takes for institutions to bring discoveries to market.”

Seema Kumar

Chief Executive Officer,Cure

Built on Rigorous
Methodology

303 institutions ranked from 6,000+ analyzed

3 dimensions, 10 subdomains, 25 indicators

Data from NIH, NSF, ClinicalTrials.gov, and more

Peer benchmarking based on deciles

Institution-level data remains private

Cure is an affiliate of Deerfield Management